# Astellas Pharma Inc., Toyama, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/astellas-pharma-inc/9a5bc049-426d-4313-b8b8-1ce28d48fa42

> Inspection records and compliance data for Astellas Pharma Inc. in Toyama. 7 FDA inspections on record, 2 Form 483s, last inspected April 18, 2024.

---

## Details

- Name: Astellas Pharma Inc.
- FEI Number: 3002807003
- Address Line 1: 2-178, Kojin-Machi
- City: Toyama
- Country Name: Japan
- Address: 2-178, Kojin-Machi, Toyama, Japan
- Country: Japan

## Related Documents

- FDA Inspection 1240584 - Astellas Pharma Inc. - 2024-04-18 — classification: No Action Indicated (NAI), source: FDA, date: April 18, 2024
- [483 - Astellas Pharma Inc. - 2019-10-07](https://www.keypedia.com/records/483/astellas-pharma-inc/23a6db75-8d9f-4df4-bf36-d0980ceca90d) — source: FDA, date: October 7, 2019
- FDA Inspection 1095974 - Astellas Pharma Inc. - 2019-05-31 — classification: No Action Indicated (NAI), source: FDA, date: May 31, 2019
- [FDA Inspection 1042616 - Astellas Pharma Inc. - 2018-03-02](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/64d4d1f9-e83d-4990-a597-13579281149e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 2, 2018
- [FDA Inspection 995338 - Astellas Pharma Inc. - 2016-11-11](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/afba335b-459c-4410-8d03-ca5cc42652ae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2016
- FDA Inspection 886636 - Astellas Pharma Inc. - 2014-06-25 — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2014
- FDA Inspection 770005 - Astellas Pharma Inc. - 2012-02-10 — classification: No Action Indicated (NAI), source: FDA, date: February 10, 2012
- FDA Inspection 548515 - Astellas Pharma Inc. - 2008-10-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2008

## Related Companies

- [Novartis d.o.o.](https://www.keypedia.com/companies/novartis-doo/55471e35-a203-4edf-a4b9-fe1ad0bb16fd)
- [Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd/484385fe-e88b-4fbd-a58d-4759ca816ab9)
- [Fresenius Kabi Austria Gmbh](https://www.keypedia.com/companies/fresenius-kabi-austria-gmbh/f0cc0bbb-a42b-4b48-9334-0426fb359254)
- [Sun Pharmaceutical Industries Limited](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/51c5d6b8-303e-4e32-bbef-eaca05e879ef)
- [Amgen Singapore Manufacturing Pte Ltd](https://www.keypedia.com/companies/amgen-singapore-manufacturing-pte-ltd/ff869a15-a7c2-441a-8165-7fd77928331e)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)
- [Novartis Pharma AG](https://www.keypedia.com/companies/novartis-pharma-ag/194ac641-5956-4430-9641-411cb975a51f)
- [Asymchem Life Science (Tianjin) Co., Ltd.](https://www.keypedia.com/companies/asymchem-life-science-tianjin-co-ltd/ccb993d1-42a4-40fe-9c05-bf590f287eeb)
- [Vistin Pharma AS avd Kragero Fikkjebakke](https://www.keypedia.com/companies/vistin-pharma-as-avd-kragero-fikkjebakke/6acc0a66-9192-481c-a1bf-4d4d0cbf68e7)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/86ee0564-73c3-4575-acbc-56fb8e87627c)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)
- [issuing_officer](https://www.keypedia.com/people/maxwell-van-tassell/dfc0fdd4-a372-41cb-8b9d-2b6a083d42e2)